28 abril 2009

La Benjamina del Grupo Zeltia ( Sylentis ) ya se Codea con la I+D de EEUU ... en lo que es "La Teconologia del Futuro" .


Bacterial particle endocytosis by epithelial cells is selective and enhanced by tumor necrosis factor-receptor ligands .

Robin T. Clark, Andrew Hope, Marta Lopez-Fraga, Neal Schiller, and David D. Lo*
Division of Biomedical Sciences, University of California, Riverside, CA 92521, USA; La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA; Allergy Department, Kaiser Permanente, Santa Clara, CA, USA; Sylentis, 28760 Madrid, Spain